The present invention relates to an improved method for determining the head and neck cancer patient prognosis. The present invention is also, it also relates to a kit comprising reagents useful in prognosis of head and neck cancer.ヘイズ,デイビッド,エヌ....
Locally advanced hypopharyngeal squamous cell carcinoma is an aggressive form of head and neck cancer with a poor prognosis. Here, the authors report the safety and efficacy of induction camrelizumab (anti-PD-1) and chemotherapy for the treatment of locally advanced hypopharyngeal squamous cell car...
“高尔基整体膜蛋白4调控头颈癌细胞增殖、凋亡和细胞周期” Abstract: The incidence of global head and neck cancer has increased markedly in the last 10 years, and its prognosis is poor, which seriously endangers people's life and health. At present, there are few studies on its pathogenesis. Gol...
human papillomavirus ; head and neck cancer ; immune system ; smokingdoi:10.3402/acmo.v2.25717Anaëlle DurayDaniel LacremansStéphanie DemoulinPhilippe DelvenneSven SaussezCo-Action PublishingAdvances in Cellular\\s&\\smolecular OtolaryngologyDuray A, Lacremans D, Demoulin S, Delvenne P, Saussez ...
Interpretable survival network for progression risk analysis of multimodality imaging biomarkers in poor-prognosis head and neck cancers Lise Wei ,Madhava P. Aryal &Yue Cao Article 27 November 2024|Open Access SLC2A3 promotes head and neck squamous cancer developing through negatively regulating CD8+...
Head and neck cancers are one of the easiest to detect. The early signs can be both seen and felt. The signs and symptoms depend on the location of the cancer: Mouth and oral cavity: a sore that does not heal within two weeks, unusual bleeding from the teeth or gums, a white or re...
Head and neck cancers (HNCs) are specifically defined as cancers of the upper aerodigestive tract, which includes the oral cavity, the mucosal lip, the oropharynx, the hypopharynx, the nasopharynx, the larynx, and the salivary glands.1Globally, HNCs were the eighth most common cancer in 2018,...
Szczepanski MJ, DeLeo AB, Luczak M, et al. PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions. Oral Oncol. 2013;49(2):144-51....
Head and neck cancer comprises a group of biologically similar cancers that start in the lip, oral cavity (mouth), nasal cavity (inside the nose), paranasal sinuses, pharynx and larynx. Most head and neck cancers are squamous cell carcinomas that originate from the epithelium of these regions...
Head and neck cancer is the sixth most common malignancy around the world, and 90% of cases are squamous cell carcinomas. In this study, we performed a systematic investigation of the immunogenomic landscape to identify prognostic biomarkers for head and neck squamous cell carcinoma (HNSCC). We...